356 related articles for article (PubMed ID: 11306689)
21. Stereoselective interactions of the enantiomers of chromanol 293B with human voltage-gated potassium channels.
Yang IC; Scherz MW; Bahinski A; Bennett PB; Murray KT
J Pharmacol Exp Ther; 2000 Sep; 294(3):955-62. PubMed ID: 10945846
[TBL] [Abstract][Full Text] [Related]
22. Blockade of HERG channels by the class III antiarrhythmic azimilide: mode of action.
Busch AE; Eigenberger B; Jurkiewicz NK; Salata JJ; Pica A; Suessbrich H; Lang F
Br J Pharmacol; 1998 Jan; 123(1):23-30. PubMed ID: 9484850
[TBL] [Abstract][Full Text] [Related]
23. Biophysical properties and molecular basis of cardiac rapid and slow delayed rectifier potassium channels.
Mitcheson JS; Sanguinetti MC
Cell Physiol Biochem; 1999; 9(4-5):201-16. PubMed ID: 10575198
[TBL] [Abstract][Full Text] [Related]
24. Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG.
Kang J; Wang L; Chen XL; Triggle DJ; Rampe D
Mol Pharmacol; 2001 Jan; 59(1):122-6. PubMed ID: 11125032
[TBL] [Abstract][Full Text] [Related]
25. Block of HERG potassium channels by the antihistamine astemizole and its metabolites desmethylastemizole and norastemizole.
Zhou Z; Vorperian VR; Gong Q; Zhang S; January CT
J Cardiovasc Electrophysiol; 1999 Jun; 10(6):836-43. PubMed ID: 10376921
[TBL] [Abstract][Full Text] [Related]
26. Blockade of the HERG human cardiac K(+) channel by the antidepressant drug amitriptyline.
Jo SH; Youm JB; Lee CO; Earm YE; Ho WK
Br J Pharmacol; 2000 Apr; 129(7):1474-80. PubMed ID: 10742304
[TBL] [Abstract][Full Text] [Related]
27. High affinity blockade of the HERG cardiac K(+) channel by the neuroleptic pimozide.
Kang J; Wang L; Cai F; Rampe D
Eur J Pharmacol; 2000 Mar; 392(3):137-40. PubMed ID: 10762666
[TBL] [Abstract][Full Text] [Related]
28. Mechanism of block and identification of the verapamil binding domain to HERG potassium channels.
Zhang S; Zhou Z; Gong Q; Makielski JC; January CT
Circ Res; 1999 May; 84(9):989-98. PubMed ID: 10325236
[TBL] [Abstract][Full Text] [Related]
29. The anti-malarial drug halofantrine and its metabolite N-desbutylhalofantrine block HERG potassium channels.
Mbai M; Rajamani S; January CT
Cardiovasc Res; 2002 Sep; 55(4):799-805. PubMed ID: 12176129
[TBL] [Abstract][Full Text] [Related]
30. Effects of Na+ channel blocker, pilsicainide, on HERG current expressed in HEK-293 cells.
Wu LM; Orikabe M; Hirano Y; Kawano S; Hiraoka M
J Cardiovasc Pharmacol; 2003 Sep; 42(3):410-8. PubMed ID: 12960687
[TBL] [Abstract][Full Text] [Related]
31. Block of wild-type and inactivation-deficient human ether-a-go-go-related gene K+ channels by halofantrine.
Sánchez-Chapula JA; Navarro-Polanco RA; Sanguinetti MC
Naunyn Schmiedebergs Arch Pharmacol; 2004 Dec; 370(6):484-91. PubMed ID: 15558243
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effects of vesnarinone on cloned cardiac delayed rectifier K(+) channels expressed in a mammalian cell line.
Katayama Y; Fujita A; Ohe T; Findlay I; Kurachi Y
J Pharmacol Exp Ther; 2000 Jul; 294(1):339-46. PubMed ID: 10871331
[TBL] [Abstract][Full Text] [Related]
33. Single HERG delayed rectifier K+ channels expressed in Xenopus oocytes.
Zou A; Curran ME; Keating MT; Sanguinetti MC
Am J Physiol; 1997 Mar; 272(3 Pt 2):H1309-14. PubMed ID: 9087606
[TBL] [Abstract][Full Text] [Related]
34. Modulation of rat erg1, erg2, erg3 and HERG K+ currents by thyrotropin-releasing hormone in anterior pituitary cells via the native signal cascade.
Schledermann W; Wulfsen I; Schwarz JR; Bauer CK
J Physiol; 2001 Apr; 532(Pt 1):143-63. PubMed ID: 11283231
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of cardiac potassium currents by pentobarbital.
Bachmann A; Mueller S; Kopp K; Brueggemann A; Suessbrich H; Gerlach U; Busch AE
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan; 365(1):29-37. PubMed ID: 11862331
[TBL] [Abstract][Full Text] [Related]
36. Structural determinants and biophysical properties of HERG and KCNQ1 channel gating.
Tristani-Firouzi M; Sanguinetti MC
J Mol Cell Cardiol; 2003 Jan; 35(1):27-35. PubMed ID: 12623297
[TBL] [Abstract][Full Text] [Related]
37. Spironolactone and its main metabolite, canrenoic acid, block human ether-a-go-go-related gene channels.
Caballero R; Moreno I; González T; Arias C; Valenzuela C; Delpón E; Tamargo J
Circulation; 2003 Feb; 107(6):889-95. PubMed ID: 12591761
[TBL] [Abstract][Full Text] [Related]
38. A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG.
Rampe D; Roy ML; Dennis A; Brown AM
FEBS Lett; 1997 Nov; 417(1):28-32. PubMed ID: 9395068
[TBL] [Abstract][Full Text] [Related]
39. K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current.
Barhanin J; Lesage F; Guillemare E; Fink M; Lazdunski M; Romey G
Nature; 1996 Nov; 384(6604):78-80. PubMed ID: 8900282
[TBL] [Abstract][Full Text] [Related]
40. Kinetic modulation of HERG potassium channels by the volatile anesthetic halothane.
Li J; Correa AM
Anesthesiology; 2002 Oct; 97(4):921-30. PubMed ID: 12357160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
